A new diabetes drug that reduces blood sugar levels and helps people lose weight has been approved south of the border.
The U-S Food and Drug Administration says the drug, Ozempic, comes in injector pens and stimulates insulin production and reduces appetite.
Ozempic was developed by Danish drug-maker Novo Nordisk. (pictured)
One study says the medication reduces long-term blood sugar levels at least 2-and-a-half times as much as a popular diabetes bill and helped participants lose two-to-three times as much weight as those in a comparison group.